Levoleucovorin inhibits LOXL2 (lysyl oxidase like-2) to control breast cancer proliferation: a repurposing approach
Author:
Affiliation:
1. Department of Anatomy, College of Medicine, King Khalid University, Abha, Asir, Kingdom of Saudi Arabia
Publisher
Informa UK Limited
Subject
Molecular Biology,General Medicine,Structural Biology
Link
https://www.tandfonline.com/doi/pdf/10.1080/07391102.2023.2224894
Reference26 articles.
1. Insilco and Invitro approaches identify novel dual PI3K/AKT pathway inhibitors to control acute myeloid leukemia cell proliferations
2. Drug repurposing for breast cancer therapy: Old weapon for new battle
3. LOXL2 expression is associated with invasiveness and negatively influences survival in breast cancer patients
4. Flibanserin: A controversial drug for female hypoactive sexual desire disorder
5. Lysyl oxidase enzymatic function increases stiffness to drive colorectal cancer progression through FAK
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The role of LOXL2 in tumor progression, immune response and cellular senescence: a comprehensive analysis;Discover Oncology;2024-06-26
2. Synthesis and In vitro Screening of Pyrazine-2-Carbohydrazide Derivatives as Potential Antimicrobial Agents;Journal of Computational Biophysics and Chemistry;2024-04-03
3. Screening of potent inhibitor from Aquilaria malaccensis Lam. against arachidonic inflammatory enzymes: an insight from molecular docking, ADMET, molecular dynamics simulation and MM-PBSA approaches;Journal of Biomolecular Structure and Dynamics;2023-10-26
4. LOXL2 in Cancer: A Two-Decade Perspective;International Journal of Molecular Sciences;2023-09-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3